Erika Carmel (IL:ERKA)
TASE:ERKA
ERKA Stock Chart & Stats
52.80
0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range37.54 - 77.58
Previous CloseN/A
VolumeN/A
Average Volume (3M)32.14K
Market Cap
₪24.33M
Enterprise Value20.35M
Total Cash (Recent Filing)₪5.06M
Total Debt (Recent Filing)₪2.48M
Price to Earnings (P/E)―
Beta0.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding46,083,576
10 Day Avg. Volume67,158
30 Day Avg. Volume32,139
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)2.08
Price to Sales (P/S)0.82
P/FCF Ratio-7.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ERKA FAQ
What was Erika Carmel’s price range in the past 12 months?
Erika Carmel lowest stock price was 37.54 and its highest was 77.58 in the past 12 months.
What is Erika Carmel’s market cap?
Erika Carmel’s market cap is ₪24.33M.
When is Erika Carmel’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Erika Carmel’s earnings last quarter?
Currently, no data Available
Is Erika Carmel overvalued?
According to Wall Street analysts Erika Carmel’s price is currently Undervalued.
Does Erika Carmel pay dividends?
Erika Carmel does not currently pay dividends.
What is Erika Carmel’s EPS estimate?
Erika Carmel’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Erika Carmel have?
Erika Carmel has 46,083,576 shares outstanding.
What happened to Erika Carmel’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Erika Carmel?
Currently, no hedge funds are holding shares in IL:ERKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Erika Carmel
Erika Carmel-Tech Ltd, an Israeli company founded in Haifa in 2007, operates globally in the medical technology sector. Formerly known as Erika B-Cure Laser Ltd until its name change in October 2025, the company is dedicated to the development, manufacturing, marketing, distribution, and sale of its B-Cure laser product line. Their offerings include the B-Cure Laser Classic, a secure and non-invasive medical device engineered for home use to alleviate both chronic and acute pain. Another key product is the B-Cure Laser Pro, a non-invasive and safe medical instrument that has received clinical validation for its effectiveness in treating a range of sudden onset and long-term conditions. These B-Cure laser therapies address a wide array of ailments. This extensive list includes Achilles tendon inflammation, burns, carpal tunnel syndrome, pain in finger joints, fibromyalgia, hip pain, discomfort following dental procedures, lower and upper back pain, neck pain, shoulder pain, knee pain, tennis elbow, other general joint pain, temporomandibular joint disorders, and various wounds.